A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.
Clinical trial NCT06466525 · RECRUITING
Trial details
- NCT number
- NCT06466525
- Sponsor
- Longevity Biotech Australia Pty Ltd (subsidiary)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-16
- Primary completion
- 2027-02-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.